Cognizant Technology Solutions
CTSH
$60.00
+2.88%
Cognizant Technology Solutions is a multinational IT services and consulting company that provides digital, technology, and business process outsourcing services to enterprise clients across financial services, healthcare, communications, media, and technology sectors. As one of the largest IT services firms globally, Cognizant differentiates itself through its global delivery model, with a significant portion of its workforce based in India, enabling cost-effective offshore outsourcing. The current investor narrative centers on Cognizant's efforts to accelerate growth through AI and digital transformation offerings, while navigating a challenging demand environment and a recent sharp stock price decline followed by a recovery. Recent news highlights the broader tech sector's AI-driven momentum, which presents both opportunities and competitive pressures for traditional IT services firms like Cognizant.…
CTSH
Cognizant Technology Solutions
$60.00
Related headlines
Investment Opinion: Should I buy CTSH Today?
Based on the analysis, CTSH is rated a Hold. The consensus recommendation is 'buy' with an average target price of $64.18, implying only 3% upside from the current price of $62.31. The thesis is that the stock is fairly valued with limited near-term upside, but with potential for long-term gains if growth accelerates. Supporting evidence includes a forward PE of 9.86x, which is a discount to the industry average of 22x, and a free cash flow yield of 6.2%, indicating solid cash generation. However, the high PEG ratio of 20.57 and gross margin compression are concerning. The rating would upgrade to Buy if the stock price drops below $55, offering a more attractive entry point, or if revenue growth consistently exceeds 10%. Conversely, it would downgrade to Sell if growth decelerates below 3% or margins continue to deteriorate. Overall, the stock appears fairly valued relative to its growth prospects, but not a compelling bargain at current levels.
Sign up to view all
CTSH 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Cognizant's growth is improving but remains modest compared to AI-focused peers, and margin pressures suggest the company is investing heavily without immediate returns. The low forward PE indicates the market is not pricing in aggressive AI-driven growth, which could be an opportunity if the company executes well. However, the high PEG ratio and competitive risks temper enthusiasm. To upgrade to bullish, we would need to see sustained revenue acceleration above 8% and margin stabilization. Conversely, a downgrade to bearish would occur if growth stalls or margins deteriorate further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $64.18 and implied upside of +7.0% versus the current price.
Average Target
$64.18
0 analysts
Implied Upside
+7.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $84
Analyst target range
Cognizant is covered by 25 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 2.21 (where 1 is strong buy and 5 is sell), indicating a moderately bullish stance. The average target price is $64.18, which implies an upside of approximately 3.0% from the current price of $62.31, suggesting that analysts see limited near-term upside. The distribution of ratings is not provided, but the recommendation mean suggests a mix of buy and hold ratings, with no strong sell signals. The target price range is from a low of $42.00 to a high of $84.00, representing a wide spread of 100% from low to high, indicating significant uncertainty about the company's future prospects. The high target of $84.00 implies a potential upside of 34.8% from the current price, which would require a substantial improvement in growth and margins, possibly driven by successful AI initiatives or a market re-rating. The low target of $42.00 suggests a downside of 32.6%, which could occur if the company faces continued revenue deceleration, margin compression, or competitive losses. Recent institutional ratings show a mix of actions, with Citigroup maintaining a Neutral rating, Baird Neutral, Wells Fargo Overweight, TD Cowen Hold, Morgan Stanley Equal Weight, and Wedbush upgrading from Neutral to Outperform in June 2026, indicating some positive sentiment but not a strong bullish consensus. The wide target range and the modest average upside suggest that analysts are cautious, and the stock may remain range-bound in the near term.
Bulls vs Bears: CTSH Investment Factors
Cognizant presents a mixed picture: improving revenue momentum and a solid balance sheet are offset by margin compression and a high PEG ratio. The bull case hinges on the company's ability to sustain growth acceleration and expand margins, while the bear case focuses on competitive pressures and valuation concerns. Currently, the evidence slightly favors the bull side given the low forward PE and analyst buy consensus, but the key tension is whether the recent growth inflection can be sustained and translate into margin recovery. If growth decelerates again or margins continue to fall, the stock could face significant downside.
Bullish
- Revenue growth accelerating: Q1 2026 revenue grew 5.83% YoY to $5.413B, up from 1.7% growth in Q4 2025, marking the third consecutive quarter of sequential growth. This indicates a positive inflection in demand, likely driven by digital and AI services.
- Strong balance sheet and liquidity: Debt-to-equity is only 0.105 and current ratio is 2.34, providing ample financial flexibility. This low leverage reduces bankruptcy risk and supports continued investment in growth initiatives and shareholder returns.
- Attractive free cash flow yield: Trailing twelve-month free cash flow is $2.47B, yielding approximately 6.2% on the current market cap. This strong cash generation supports dividends, buybacks, and potential acquisitions, enhancing shareholder value.
- Undervalued on forward earnings: Forward PE is 9.86x, well below the industry average of 22x, suggesting the market is pricing in limited growth. If the company meets EPS estimates of $6.26, the stock offers significant upside potential.
Bearish
- Gross margin compression: Gross margin fell from 33.59% in Q1 2025 to 29.63% in Q1 2026, a significant decline of nearly 400 basis points. This suggests rising costs, possibly from AI investments or pricing pressure, which could erode profitability.
- High PEG ratio signals overvaluation: The PEG ratio is 20.57, extremely high due to low growth relative to PE. This indicates the stock is overvalued relative to its growth rate, making it vulnerable to de-rating if growth fails to accelerate.
- Negative 1-year price performance: The stock is down 12.79% over the past year, underperforming the S&P 500's +18.65% gain. This relative weakness suggests persistent investor concerns about the company's growth prospects and competitive position.
- Wide analyst target range: Analyst targets range from $42 to $84, a 100% spread, indicating high uncertainty. The low target implies a 32.6% downside from the current price, reflecting significant bearish scenarios.
CTSH Technical Analysis
Cognizant's stock has experienced a volatile year, with a 1-year price change of -12.79%, indicating a net decline despite a recent recovery. The current price of $62.31 sits at approximately 55% of the 52-week range (low $37.08, high $87.03), suggesting the stock is in the lower half of its yearly range, reflecting a significant drawdown from its highs. This positioning implies that the stock is neither at extreme lows nor highs, but the negative 1-year return and the fact that it is well below the 52-week high point to a market that has been punishing the stock, possibly due to growth concerns or sector rotation. The stock's beta of 0.83 indicates it is less volatile than the broader market, which may appeal to risk-averse investors, but the 55% max drawdown over the period highlights substantial downside risk.
Beta
0.83
0.83x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$37-$87
Price range past year
Annual Return
-15.0%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | +3.1% | -1.1% |
| 3m | +15.0% | +3.0% |
| 6m | -0.6% | +15.4% |
| 1y | -15.0% | +16.2% |
| ytd | -26.2% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Cognizant's revenue trajectory shows a recovery, with the most recent quarter (Q1 2026) reporting revenue of $5.413 billion, up 5.83% year-over-year, a notable acceleration from the prior quarter's 1.7% growth (Q4 2025 revenue of $5.333 billion vs. $5.082 billion in Q4 2024). This marks the third consecutive quarter of sequential revenue growth, from $5.115 billion in Q1 2025 to $5.245 billion in Q2 2025, $5.415 billion in Q3 2025, and $5.333 billion in Q4 2025, indicating a positive trend. However, the growth is modest compared to the company's historical double-digit expansion, and the revenue segments show that Financial Services ($1.644 billion) and Healthcare ($1.579 billion) are the largest contributors, while Communication, Media, and Technology ($869 million) is the smallest, suggesting a diversified but not high-growth portfolio. The company's net income for Q1 2026 was $662 million, with a net margin of 12.23%, which is stable compared to the prior year's Q1 margin of 12.96%, indicating slight margin compression. Gross margin for Q1 2026 was 29.63%, down from 33.59% in Q1 2025, reflecting a significant decline, likely due to increased costs or a shift in service mix. Operating margin also decreased to 15.09% from 16.68% in the year-ago quarter, suggesting that the company is facing cost pressures, possibly from investments in AI and digital capabilities. Cognizant's balance sheet remains solid with a debt-to-equity ratio of 0.105, indicating low leverage, and a current ratio of 2.34, showing strong liquidity. The company generated $274 million in operating cash flow in Q1 2026, down from $400 million in Q1 2025, and free cash flow of $198 million, a decline from $323 million, which could signal working capital challenges. However, the trailing twelve-month free cash flow is $2.47 billion, and the company has a history of strong cash generation, with a free cash flow yield of approximately 6.2% based on the current market cap, which is attractive. Return on equity is 14.85%, indicating efficient use of equity, and the company continues to return capital to shareholders through dividends and buybacks, with $159 million in dividends and $444 million in share repurchases in Q1 2026.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
29.6%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
Given that Cognizant has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 18.20x, while the forward PE is 9.86x, a significant gap that implies the market expects a substantial increase in earnings per share (EPS) in the next year, likely due to cost savings or growth initiatives. The forward PE of 9.86x is based on estimated EPS of $6.26, which is a 350% increase from the trailing EPS of $1.39 (Q1 2026 annualized), which seems unrealistic and may be due to a data anomaly or one-time items, so investors should verify the estimates. Compared to the industry average PE of 22x (based on typical IT services sector), Cognizant's trailing PE of 18.20x is at a 17% discount, suggesting the stock is undervalued relative to peers, which could be justified by its slower growth relative to some competitors. The PEG ratio is 20.57, which is extremely high, indicating that the stock is overvalued relative to its growth rate, but this is skewed by the low growth rate and the high forward PE gap. Historically, Cognizant's PE has ranged from around 11x to 21x over the past few years, with the current trailing PE of 18.20x near the higher end of that range, suggesting that the market is pricing in optimistic expectations for future growth, which may not be warranted given the modest revenue growth. The price-to-sales ratio is 1.89x, which is lower than the historical average of around 7x, but this is due to the recent price decline and the fact that the historical PS ratios were based on much higher prices, so the current PS is actually at a discount to its own history, indicating potential value.
PE
18.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Cognizant's gross margin compression from 33.59% to 29.63% YoY is a red flag, indicating potential cost pressures or pricing challenges. Operating cash flow declined from $400M to $274M in Q1, and free cash flow fell from $323M to $198M, which could signal working capital issues or increased investment needs. While the debt-to-equity ratio of 0.105 is low, the company's reliance on continued growth to justify its valuation is a risk, especially if revenue growth stalls. The high PEG ratio of 20.57 suggests that the market is paying a premium for growth that may not materialize, making the stock vulnerable to earnings disappointments.
FAQ
The key risks include: 1) Margin compression, as gross margin fell from 33.59% to 29.63% YoY, which could continue to pressure profitability. 2) Competitive threats from larger IT services firms and specialized AI companies that could take market share. 3) Macroeconomic sensitivity, given its beta of 0.83, but a global IT spending slowdown could hurt growth. 4) Company-specific execution risks, such as the ability to successfully integrate AI offerings and manage costs. The most severe risk is a prolonged growth deceleration, which could lead to a de-rating and a drop to the analyst low target of $42, a 32.6% downside.
The 12-month forecast is based on three scenarios: a bull case (25% probability) with a target range of $70-$84, driven by accelerated growth and margin recovery; a base case (50% probability) with a target range of $60-$68, reflecting modest growth and stable margins; and a bear case (25% probability) with a target range of $42-$50, if growth stalls and margins compress. The most likely scenario is the base case, which aligns with the analyst average target of $64.18, implying a 3% upside. The key assumption is that revenue growth continues at around 5% and margins stabilize.
CTSH appears fairly valued on a trailing PE basis at 18.20x, which is a 17% discount to the industry average of 22x, but the forward PE of 9.86x suggests the market expects significant EPS growth. The PEG ratio of 20.57 is extremely high, indicating overvaluation relative to its growth rate, but this is skewed by the low growth. Compared to its own history, the trailing PE is near the higher end of its 11x-21x range, implying the market is pricing in optimistic expectations. The price-to-sales ratio of 1.89x is below its historical average, suggesting potential value. Overall, the stock is not clearly overvalued or undervalued, but the high PEG ratio is a warning sign.
CTSH is a reasonable buy for value-oriented investors with a medium-term horizon, given its low forward PE of 9.86x and free cash flow yield of 6.2%. The analyst consensus is 'buy' with an average target of $64.18, implying a modest 3% upside, which suggests limited near-term gains. However, the stock carries risks such as gross margin compression and a high PEG ratio of 20.57, which could lead to downside if growth disappoints. It is a better buy on dips below $55, where the risk/reward becomes more favorable. For growth-focused investors, there are more compelling opportunities in the market.
CTSH is more suitable for long-term investment, given its low beta of 0.83 and stable cash flows, which provide downside protection. The stock's growth is modest, so it may not offer significant short-term trading opportunities, but its low forward PE and free cash flow yield could lead to capital appreciation over a 3-5 year horizon if the company successfully navigates the AI transition. The dividend yield of 1.53% adds to total return potential. For short-term traders, the stock's volatility (max drawdown -55%) offers opportunities, but the wide analyst target range indicates uncertainty. A minimum holding period of 3 years is recommended to ride out cyclicality and capture the potential re-rating.